BCRX three-lens brief
Evidence-based stock research on BCRX. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Price down 5.85% in the last session — a material single-day move. · Trading >3% below the 50-day MA — short-term weakness.
- Price down 5.85% in the last session — a material single-day move.
- Trading >3% below the 50-day MA — short-term weakness.
- Underperforming SPY by 16.9pp over 30 days.
- P/E of 7.0 — trading at a value multiple.
- Analyst mean target $20.82 — 151% above current (11 analysts).
BCRX closed at $8.29 (-5.85%) as of 2026-09-11. Market cap: $2.12B. P/E (trailing) 7.0. Price is below the 50-day MA and below the 200-day MA. Positives: p/E of 7.0 — trading at a value multiple.; analyst mean target $20.82 — 151% above current (11 analysts).. Concerns: price down 5.85% in the last session — a material single-day move.; trading >3% below the 50-day MA — short-term weakness.. Last quarter: Revenue $218.25M, net income $78.39M, free cash flow $323.67M.
Why three lenses on BCRX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BCRXacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BCRX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BCRX brief"></iframe>